Mortality difference by dialysis modality among new ESRD patients with and without diabetes mellitus

Dialysis and Transplantation

Volumn 35, Issue 4, 2006, Pages 234-244

  Lin, Ting Chia ^a   Kao, Min Tsung ^a   Lai, Ming Nan ^a   Huang, Chiu Ching ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; SERUM ALBUMIN;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GOUT; HEART ARRHYTHMIA; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PEPTIC ULCER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; TREATMENT DURATION;

EID: 35748954304     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: 10.1002/dat.20015     Document Type: Article

References (20)

1. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: A reexamination. Am J Kidney Dis. 1989;13:200-209.
2. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA. 1993;270: 1339-1343.
3. Nolph KD, Popovich RP, Moncrief JW. Theoretical and practical implications of continuous ambulatory peritoneal dialysis. Nephron. 1978;21:117-122.
4. Bloembergen W, Port F, Mauger E, Wolfe R. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1995;6:177-183.
5. Fenton SS, Schaubel DE, Desmeules M, etal. Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates. Am J Kidney Dis 1997;30:334-342.
6. Vonesh EF, Moran J. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol. 1999;10:354-365.
7. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1999;34:1065-1074.
8. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int. 2004;66:2389-2401.
9. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR. Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1997;8: 965-971.
10. Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 1994;23:661-669.
11. Keshaviah P, Collins AJ, Ma JZ, Churchill DN, Thorpe KE. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol 2002;13:S48-S52.
12. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-564.
13. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620-626.
14. Powe NR, Jaar B, Furth SL, et al. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081-1090.
15. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol. 1998; 9:1285-1292.
16. Schwedler S, Schnizel S, Valth P, Wanner C. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? Kidney Int. 2001;59:S32-S36.
17. United States Renal Data System: Causes of death. Am J Kidney Dis 1999;34:S87-S94.
18. Lameire N, Vanholder R, De Smet R. Uremic toxins and peritoneal dialysis. Kidney Int. 2001;78:S292-S297.
19. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol. 2003;14:415-424.
20. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int. 2003;64:1071-1079.